Clinical Practice

Use the tool below to view all available Global Neurology Academy Series

Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
Global Neurology Academy
Advancing MS Care: Diagnostic Clarity, Early Action, and Patient-Centered Treatment
- Tirisham V. Gyang, MD
- Gates B. Colbert, MD
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Global Neurology Academy
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
- Vikram V. Bhise, MD
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Global Neurology Academy
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
- Ashley Baker, MSN, PMHNP
- Jay Avasarala, MD, PhD
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
NeuroFrontiers
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
- Michael Levy, MD, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiers
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
- Le Hua, MD
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
- Ryan Quigley
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiers
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiers
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
- Marc Haut, PhD
Addressing Barriers to MenB and MenACWY Vaccination
Addressing Barriers to MenB and MenACWY Vaccination
Global Neurology Academy
Addressing Barriers to MenB and MenACWY Vaccination
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Global Neurology Academy
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
NeuroFrontiers
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiers
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Understanding MS: Managing Hidden and Overlooked Symptoms
Understanding MS: Managing Hidden and Overlooked Symptoms
Global Neurology Academy
Understanding MS: Managing Hidden and Overlooked Symptoms
- Marisa McGinley, DO
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context
NeuroFrontiers
ASD in Children with SMA Type I: Diagnostic Challenges in a Multifactorial Context

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Share on ReachMD